Representative Katie Porter, (D-CA) does her homework, and she knows her numbers, and when she whips out her white board, someone is in for a can of whup ass.

In this case, it was the Richard Gonzalez, the CEO of AbbVie, which is gouging patients for its Humira Arthritis drug.

She showed that the money for R&D is dwarfed by advertising, and executive compensation, particularly that compensation which is driven by stock buybacks:

Or, as Porter observed: “You lie to patients when you charge them twice as much for an unimproved drug, when you tell us that R&D justifies those price increases. The Big Pharma fairy tale is one of groundbreaking R&D that justifies astronomical prices. But the pharma reality is that you spend most of that money making money for yourself and your shareholders.”

Roll the tape, it’s beautiful: (It’s also not that difficult if you aren’t spending 8 hours a day dialing for dollars for your DCCC dues)